Targeted gut microbiota manipulation attenuates seizures in a model of infantile spasms syndrome
Open Access
- 22 June 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (12)
Abstract
Infantile spasms syndrome (IS) is a devastating early-onset epileptic encephalopathy associated with poor neurodevelopmental outcomes. When first-line treatment options, including adrenocorticotropic hormone and vigabatrin, are ineffective, the ketogenic diet (KD) is often employed to control seizures. Since the therapeutic impact of the KD is influenced by the gut microbiota, we examined whether targeted microbiota manipulation, mimicking changes induced by the KD, would be valuable in mitigating seizures. Employing a rodent model of symptomatic IS, we show that both the KD and antibiotic administration reduce spasm frequency and are associated with improved developmental outcomes. Spasm reductions were accompanied by specific gut microbial alterations, including increases in Streptococcus thermophilus and Lactococcus lactis . Mimicking the fecal microbial alterations in a targeted probiotic, we administered these species in a 5:1 ratio. Targeted probiotic administration reduced seizures and improved locomotor activities in control diet–fed animals, similar to KD-fed animals, while a negative control ( Ligilactobacillus salivarius ) had no impact. Probiotic administration also increased antioxidant status and decreased proinflammatory cytokines. Results suggest that a targeted probiotic reduces seizure frequency, improves locomotor activity in a rodent model of IS, and provides insights into microbiota manipulation as a potential therapeutic avenue for pediatric epileptic encephalopathies.Keywords
Funding Information
- Alberta Children’s Hospital Research Institute, the Owerko Centre (Translation Autism Research Program 10022770)
- Natural Sciences and Engineering Research Council of Canada (RGPIN/04238-2018)
This publication has 58 references indexed in Scilit:
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissuesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Dietary treatments for epilepsy: Management guidelines for the general practitionerEpilepsy & Behavior, 2011
- Infantile spasms treated with the ketogenic diet: Prospective single‐center experience in 104 consecutive infantsEpilepsia, 2010
- A model of symptomatic infantile spasms syndromeNeurobiology of Disease, 2010
- METLINTherapeutic Drug Monitoring, 2005
- Immune‐Modulating Effects of Melatonin, N‐Acetylserotonin, and N‐AcetyldopamineAnnals of the New York Academy of Sciences, 2005
- β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionNature, 2005